Latest news
Sionna Therapeutics, Inc. 2026 Q2 Report: Clinical Progress, Key Risks, and Financial Highlights - MinichartMinichart · Fri, 07 Aug 2026 00:10:00 GMTOABI: Revenue growth and clinical progress drove improved outlook and reduced net loss - TradingViewTradingView · Thu, 06 Aug 2026 22:47:01 GMTVSTM: Strong Q2 revenue, robust funding, and clinical progress position the business for sustained growth - TradingViewTradingView · Thu, 06 Aug 2026 21:52:35 GMTVSTM: Strong Q2 revenue, enhanced cash, and clinical progress drive positive outlook for 2026 - TradingViewTradingView · Thu, 06 Aug 2026 20:42:28 GMTRLAY: Strong cash position and clinical progress drive continued investment despite higher net loss - TradingViewTradingView · Thu, 06 Aug 2026 20:06:55 GMTSABS: Strong clinical progress and financial position support SAB-142's advancement in T1D - TradingViewTradingView · Thu, 06 Aug 2026 13:52:46 GMTCGON: Strong clinical progress and robust cash position support long-term operational runway - TradingViewTradingView · Thu, 06 Aug 2026 12:33:11 GMTMiNK Therapeutics to Report Second Quarter 2026 Financial Results and Provide Corporate Update on agenT-797 Clinical Progress - quiverquant.comquiverquant.com · Thu, 06 Aug 2026 12:30:00 GMT